Treatments Biggest Accomplishment for Lymphoma Research in 2009
In an interview with Dr. Brad Kahl at the UW Carbone Cancer Center, he explains one of the biggest accomplishments for lymphoma research in 2009 was proof that the combination of Bendamustine and Rituximab is the best frontline treatment for newly diagnosed follicular lymphoma patients.
Other video segments available in this category
Get More from Forward Lymphoma
Sign up to receive more information from Forward Lymphoma and the Carbone Cancer Center.
Download the Helping Lymphoma Patients with Research Focused on Psychological Recovery white paper.
Download the Determining Who is Right for Rituximab white paper.
Download the Using Stem Cells to Develop Patient Specific Treatments white paper.
